1.8500
+0.0600
+(3.35%)
At close: April 17 at 4:00:00 PM EDT
1.8800
+0.03
+(1.62%)
After hours: April 17 at 7:44:37 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.07 | -0.07 | -0.27 | -0.12 |
| Low Estimate | -0.09 | -0.08 | -0.3 | -0.22 |
| High Estimate | -0.06 | -0.05 | -0.21 | -0.07 |
| Year Ago EPS | -0.06 | -0.07 | -0.3 | -0.27 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | 6.88M | 7.72M | 33.23M | 53.35M |
| Low Estimate | 6.5M | 7.3M | 31.9M | 42.2M |
| High Estimate | 7.1M | 8.6M | 35.3M | 60.9M |
| Year Ago Sales | 6.88M | 4.5M | 26.92M | 33.23M |
| Sales Growth (year/est) | -0.07% | 71.59% | 23.43% | 60.57% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.06 | -0.05 | -0.05 | -0.06 |
| EPS Actual | -0.06 | -0.07 | -0.08 | -0.09 |
| Difference | 0 | -0.02 | -0.03 | -0.02 |
| Surprise % | 4.00% | -33.33% | -52.38% | -38.46% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.07 | -0.07 | -0.27 | -0.12 |
| 7 Days Ago | -0.07 | -0.07 | -0.27 | -0.12 |
| 30 Days Ago | -0.07 | -0.07 | -0.27 | -0.12 |
| 60 Days Ago | -0.04 | -0.03 | -0.19 | -0.07 |
| 90 Days Ago | -0.04 | -0.03 | -0.19 | -0.07 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | 3 | 3 | -- | 1 |
| Down Last 30 Days | 3 | 3 | 4 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| STXS | -20.83% | 0.00% | 10.00% | 53.70% |
| S&P 500 | 7.04% | 4.85% | 8.57% | 14.16% |
Upgrades & Downgrades
| Maintains | Lake Street: Buy to Buy | 3/5/2024 |
| Reiterates | Roth MKM: Buy to Buy | 3/5/2024 |
| Initiated | Roth MKM: Buy | 1/10/2024 |
| Maintains | Piper Sandler: Overweight | 3/6/2023 |
| Maintains | Lake Street: Buy | 3/6/2023 |
| Maintains | B. Riley Securities: Buy | 3/6/2023 |
Related Tickers
KRMD KORU Medical Systems, Inc.
2.2700
-0.87%
HBIO Harvard Bioscience, Inc.
0.3880
-0.51%
SR3.F STAAR Surgical Company
14.19
-1.11%
FSPKF Fisher & Paykel Healthcare Corporation Limited
16.35
0.00%
CLPBF Coloplast A/S
98.61
0.00%
EKSO Ekso Bionics Holdings, Inc.
0.4120
+7.29%
NXGL NEXGEL, Inc.
2.8300
0.00%
SMTI Sanara MedTech Inc.
29.43
+2.58%
AP4.SI Riverstone Holdings Limited
0.8900
+0.56%
GCTK GlucoTrack, Inc.
0.1590
-3.05%